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Table 2. Data from exercise stress testing and electrocardiographic exami-
nation of the study groups
Controls (n=32)
Cigarette smokers
(n=32)
Maras powder
users (n=30)
Resting heart rate
(bpm)
88.014.4 90.513.5 91.812.7
Peak heart rate
(bpm)
179.37.7 174.512.0 170.210.6 *
METs 13.81.2 13.50.8 13.21.3
Exercise duration
(min)
11.01.6 10.51.1 10.31.4
Chronotropic
response
0.890.10 0.880.11 0.830.13
CI, n (%) 4 (12.5) 8 (25.0) 12 (40.0) U
HRR 1 36.110.4 35.313.5 29.59.1 #
HRR 1 18, n (%) 1 (3.1) 2 (6.2) 5 (16.6)
cQTd (ms) 37.415.1 38.87.1 42.423.8
cTp-e (ms) 87.39.9 83.512.5 85.78.7
Tp-e/QT 0.210.02 0.200.03 0.210.02
CI: Chronotropic incompetence, HRR 1: heart rate recovery at 1 minute after exercise
termination, cQTd: corrected QT disperison, cTp-e: corrected transmural dispersion of repo-
larization. *: p=0.003 vs controls, U: p=0.02 vs controls, #: p=0.076 vs controls.
Table 1. Demographic and laboratory characteristics of the groups
Controls (n=32)
Cigarette
smokers
(n=32)
Maras powder
users (n=30)
Age (years) 33.67.0 33.76.1 34.05.7
BMI (kg/m2) 25.23.5 25.83.4 27.14.3
Systolic BP (mmHg) 122.37.3 119.27.2 120.28.1
Diastolic BP (mmHg) 77.26.2 76.75.0 75.95.4
Heart rate (beats/min) 77.010.3 79.012.0 78.010.2
LV EDD (mm) 46.73.3 47.43.1 47.63.4
LV EF (%) 66.82.6 67.43.9 66.12.4
LV mass index (g/m2) 89.313.7 89.114.4 92.612.5
Glucose (mg/dl) 87.712.7 92.614.4 94.425.6
Hemoglobin (g/dl) 15.30.8 15.40.9 15.30.9
WBC (k/ul) 78701733 82092460 79452040
Neutrophils (%) 55.38.7 57.06.9 59.07.8
Lymphocytes (%) 34.27.8 31.95.9 29.66.7 *
N/L ratio 1.80.7 1.90.6 2.20.8
Mean platelet volume (ﬂ) 8.94.1 8.50.7 8.30.7
CRP (mg/l) 4.12.5 3.81.4 3.61.8
Uric acid (mg/dl) 14.12.4 15.02.7 15.72.5
GGT (U/l) 18.611.9 22.412.4 27.514.9 #
BMI: body mass index, BP: blood pressure, LV EDD: left ventricular end-diastolic dimension,
LV EF: left ventricular ejection fraction, LV: left ventricular, WBC: white blood count, N/L ratio:
Neutrophils to lymphocytes ratio, CRP: C-reactive protein, GGT: gama glutamil transferas.
*: p=0.045 vs controls, #: 0.049 vs controls.
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Background: The value of conventional non-invasive brachial artery pressure
parameters in prediction left ventricular end-diastolic pressure (LVEDP) is vague. In
this study, we aimed to investigate any potential relationship between brachial artery
fractional pulse pressure (FPP), pulsatility index (PI) and invasive measurement of
LVEDP in patients undergoing left heart catheterization due to suspected ischemic
heart disease.JACC Vol 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTMethods: In this observational study, a total of 93 patients who underwent coronary
angiography due to suspected ischemic heart disease were included. Patients with
non-sinus rhythm, chronic obstructive lung disease, acute coronary syndrome,
primary pulmonary hypertension, constrictive pericarditis, moderate or severe mitral
or aortic stenosis and regurgitation, and those with problems in measurement of
LVEDP were excluded. Study population was selected by nonrandomized sampling
method. The patients with < LVEDP 18 mmHg constituted the group 1, and >18
mmHg group 2. LVEDP was initially measured invasively by cardiac catheteriza-
tion. Subsequently, systolic and diastolic pressure along with FPP (pulse pressure/
mean pressure) and PI (pulse pressure/diastolic pressure) were measured non-
invasively from brachial artery using sphygmomanometer. Informed consent was
obtained from each patient.
Results: The mean age of the study population (n¼93) was 5413 (M:48, F:45).
There were no signiﬁcant differences between groups regarding age, gender and
atherosclerotic risk factors. The mean invasively measured LVEDP was 176.3
mmHg. The noninvasively measured FPP levels were 0.720.2 and PI 10.39.
FPP levels were signiﬁcantly different between group 1 and 2 (0.650.19,
0.810.16, respectively, p¼0.001), whereas there was no statistical difference in
terms of PI (10.4, 0,990,38, respectively, p¼0.980). There was a moderate
positive correlation between noninvasively measured FPP and invasively measured
LVEDP (r:0.341, p¼0.007). No correlation was observed between PI and LVEDP
(r:-0.38, p¼0.773). ROC curve analysis was performed to detect the best cut-off
value of FPP in the prediction of increased LVEDP. FPP value >0.69 yielded an
AUC value of 0.720 (95% CI 0.593-0.847) (p:0.003). Furthermore, FPP of >0.69
value demonstrated a sensitivity of 67% and speciﬁcity of 69% for the increase in
LVEDP.
Conclusıon: Noninvasively measured brachial artery fractional pulse pressure has
a signiﬁcant relationship with the invasively measured LVEDP.
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Introductıon: The aim of the study is to evaluate the gene polymorphisms in a group
of adolescents with a family history of premature atherosclerosis.
Methods: Thirty-six subjects who have a father with a history of obstructive coronary
artery disease before the age 40 and 46 subjects who have a father with normal
coronary arteries documented with coronary angiography were included to the study.
The C-reactive protein (CRP), endothelial nitric oxide synthase (eNOS), and inter-
leukin-6 (IL-6) polymorphisms were analyzed by retraction fragmented length poly-
morphism technique.
Results: There were no differences between the two groups regard to age, sex, body
mass index, systolic and diastolic blood pressures, lipid proﬁle, serum creatinine, and
fasting glucose, hemoglobin, and high sensitivity CRP (Table 1). A signiﬁcant
difference was observed only in IL-6 -572 G/C genotype distribution and allele
frequency between two groups (P¼0.012) (Table 2).
Conclusion and Dıscussıon: The present study showed a signiﬁcant and independent
association between the IL-6-572 G/C gene polymorphism (presence of C allele) and
adolescents with a family history of premature atherosclerosis.ERS C125
Table 1
Kontrol Distal VTE
Proksimal
VTE PTE P value
NLR 1.800.70 2.731.34 3.221.26 4.101.40 <0.001
WBC 6.50.95 6.61.76 8.22.26 10.12.8 <0.001
Hs-CRP 0.680.35 0.650.35 1.541.33 3.483.95 <0.001
The distribution of NLR, WBC and hs-CRP values between the control group and the sub-
groups of VTE. Abbreviations: NLR, neutrophil to lymphocyte ratio; WBC, white blood cell; hs-
CRP, high-sensitivity C-reactive protein.
Table 1. Baseline characteristics and laboratory ﬁndings of the study groups
Variables
Control group
(n=46)
Risky group
(n=36) P value
Age (years) 13.911.31 14.561.73 0.060
Gender (Male) 26 (57) 20 (56) 0.930
Body mass index
(kg/m2)
19.783.25 20.293.59 0.500
Systolic blood
pressure (mmHg)
111.8512.75 113.3114.73 0.633
Diastolic blood
pressure (mmHg)
69.468.11 72.449.10 0.121
Total cholesterol
(mg/dl)
156.7627.62 165.1235.60 0.403
Triglyceride (mg/dl) 112.3555.16 104.9148.44 0.626
LDL-C (mg/dl) 84.2322.26 93.7632.30 0.282
HDL-C (mg/dl) 63.6513.41 56.5514.95 0.106
Creatinine (mg/dl) 0.490.11 0.510.13 0.644
Fasting glucose
(mg/dl)
87.639.91 90.279.19 0.275
Hemoglobin (g/dl) 12.350.85 12.311.25 0.899
hs-CRP (mg/L) 0.46 [0.24-1.62] 0.36 [0.23-0.75] 0.582
LDL-C low-density lipoprotein cholesterol; HDL high-density lipoprotein cholesterol; hs-CRP
high sensitivity C-reactive protein. Data are shown as n (%), meanSD, median [IQR].
Table 2. Distribution of genotype and allele frequencies and odds ratios and
95% conﬁdential intervals of the atherosclerosis risk among CRP, eNOS, and
IL-6 polymorphisms
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CRP +1444 C/T
Genotypes 0.585
C/C 24 (52.2) 16 (44.4)
C/T 19 (41.3) 19 (52.8)
T/T 3 (6.5) 1 (2.8)
Alleles 0.390 1.10 (0.56-2.18)
C 67 (72.8) 51 (70.8)
T 25 (27.2) 21 (29.2)
eNOS -786 T/C
Genotypes 0.502
T/T 28 (60.9) 18 (50.0)
T/C 11 (23.9) 13 (36.1)
C/C 7 (15.2) 5 (13.9)
Alleles 0.255 1.26 (0.64-2.46)
T 67 (72.8) 49 (68.1)
C 25 (27.2) 23 (31.9)
IL-6 -572 G/C
Genotypes 0.012
G/G 42 (91.3) 25 (69.4)
G/C 3 (6.5) 10 (27.8)
C/C 1 (2.2) 1 (2.8)
Alleles 0.012 3.48 (1.17-10.32)
G 87 (94.5) 60 (83.3)
C 5 (5.4) 12 (16.6)
CRP C-reactive protein, NOS nitric oxide synthase, IL-6 interleukin-6. Data are shown as n (%).
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Objectıve: The aim of this study was to investigate the relationship between the
anatomic extent of venous thromboembolism (VTE) and nonspeciﬁc inﬂammatoryC126 JACC Vomarkers such as Neutrophil to lymphocyte ratio (NLR) and high-sensitivity C-reactive
protein (hs-CRP).
Methods: We retrospectively enrolled 77 patients with VTE (Distal deep vein
thrombosis (DVT) (n¼19), proximal DVT (n¼32) and pulmonary thomboembolism
(PTE) (n¼26)) and 34 healthy controls. Distal and proximal DVT was diagnosed by
using peripheral vascular duplex ultrasonography. Proximal DVT was deﬁned as
thrombosis at the level of the popliteal veins or above. Distal DVT was deﬁned as
thrombosis occurring within the calf veins. The diagnosis of PTE was conﬁrmed in all
cases by computed tomography. Total and differential leukocyte count and hs-CRP
were determined by standard laboratory.
Results: It was detected in patients with VTE that WBC (8.50.26 vs 6.50.95,
p<0.001), NLR (3.411.41 vs 1.800.70, p<0.001) and hs-CRP(2.002.68 mg/L vs
0.680.35 mg/L, p¼0.005) levels were signiﬁcantly higher in comparison with the
healthy control group. According to the analysis made by ANOVA, the levels of
WBC, NLR and hs-CRP were clearly different among the groups (control, distal and
proximal DVT and PTE) (p<0.001). According to ANOVA test with LSD as a post-
hoc test performed to ﬁnd the source of the difference between the groups, only hs-
CRP was found high in PTE group in comparison with the other groups; and no
difference was detected between the other groups. A signiﬁcant increase from the
control group to DVT and PTE was observed in the analysis made for NLR. In the
analysis for WBC, while there was no difference between the control group and distal
DVT, it was found signiﬁcantly higher in the proximal DVT and PTE (Table 1). ROC
curve analysis was performed in order to ﬁnd the best cut-off values of these variables
in predicting VTE. AUC:0.849, p<0.001 was detected for NLR>1.84. For this value,
sensitivity as 88.2% and speciﬁty as 67.6% was determined. AUC:0.741, p<0.001
was detected for Hs-CRP>1.17. For this value, sensitivity as 45.6% and speciﬁty as
94.1% was determined. For WBC>7.7, AUC:0.761, p<0.001 was detected. For this
value, sensitivity as 57.4% and speciﬁty as 91.2% was determined. ROC curve-AUC
values of each three variables were compared. While there was no signiﬁcant
difference between hs-CRP and WBC (p¼0.742), it was observed that there was
a clear difference between both NLR and WBC (p¼0.078), and NLR and hs-CRP
(p¼0.044) (Figure 1).
Conclusıons: These ﬁndings suggest that the inﬂammatory process might have an
important role in the prothrombotic state in patients with VTE. Also, NLR may be
effective in determining the anatomic extent of VTE. NLR is inexpensive and
readily available markers that may be useful for risk stratiﬁcation in patients with
VTE.PP-113
Serum Uric Acid Level is correlated with Decreased Blood Flow Velocity of Left
Atrial Appendage in Patients with Atrial Fibrillation
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Objectıve: The coexisting clinical, echocardiographic and biochemical risk factors
have been identiﬁed in relation to an increased risk of thromboembolism in patientsl 62/18/Suppl C j October 26–29, 2013 j TSC Abstracts/POSTERS
